losartan has been researched along with Infections, Plasmodium in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, LS | 1 |
| Peruchetti, DB | 1 |
| Silva-Aguiar, RP | 1 |
| Abreu, TP | 1 |
| Dal-Cheri, BKA | 1 |
| Takiya, CM | 1 |
| Souza, MC | 1 |
| Henriques, MG | 1 |
| Pinheiro, AAS | 1 |
| Caruso-Neves, C | 1 |
1 other study available for losartan and Infections, Plasmodium
| Article | Year |
|---|---|
The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting | 2018 |